Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mei Lin Liao"'
Autor:
Tonu Vanakesa, Oleg Gladkov, Katalin Udud, Patrick Therasse, Byoung Chul Cho, Jean-Louis Pujol, Moon Soo Kim, Libor Havel, Johan Vansteenkiste, Hans Hoffman, Nasser K. Altorki, Haruhiko Kondo, Paul D. Taylor, Jacek Jassem, Marcin Zieliński, Mei Lin Liao, Jamila Louahed, Tetsuya Mitsudomi, Tommaso De Pas, Konstantinos Zarogoulidis, Anders Bugge, Jubrail Dahabreh, Vincent Brichard, Muriel Debois, Haruhiku Nakayama, Jianxing He, Hirohito Tada, Masahiro Yoshimura, Emilio Esteban Gonzalez, C. Debruyne
Publikováno v:
The Lancet Oncology. 17:822-835
Summary Background Fewer than half of the patients with completely resected non-small-cell lung cancer (NSCLC) are cured. Since the introduction of adjuvant chemotherapy in 2004, no substantial progress has been made in adjuvant treatment. We aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cfba095f4c0d44aa7a2da0e05af827f
https://doi.org/10.1016/s1470-2045(16)00099-1
https://doi.org/10.1016/s1470-2045(16)00099-1
Autor:
Bao Hui Han, Yunpeng Liu, Jian Ping Xiong, Peng Hui Zhou, Yong Song, Xiaolong Fu, Wei Min Mao, Yuan Chen, Jizhen Lin, Gang Wu, Lin Wu, Jian Hua Chang, Wen-Zhao Zhong, Yun Fan, Jie Wang, Chun Chen, Jun Liang, Chang Li Wang, Wen Fan, Hao Sun, Shun Lu, Cheng Huang, Zhe Liu, Sheng Lin Ma, Jian Jun Wang, Gui Bin Qiao, Nong Yang, Qing Zhou, Yong He, Cai Cun Zhou, Cheng Ping Hu, He Long Zhang, Ji Feng Feng, Mei Lin Liao, Bo Zhu, Qun Wang, Qiong Zhao, X. Zhang, Qi Bin Song, Jie Hu, Zhong Zhen Guan, Chen Yan Gao, Yi-Long Wu, X.-N. Yang, Jin Ji Yang, Yue Yin Pan, Fan Yang, Ming Fang Zhao, Ying Cheng, Xiaoqing Liu, Jun Zhao, Yi Hu, Yan Fang Guan, Nan Wu, Ke-Neng Chen, Zhi Yong Ma
Publikováno v:
Translational lung cancer research. 7(3)
The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89abbe1e8c35cc1f558ab9d1cc70881
https://pubmed.ncbi.nlm.nih.gov/30050780
https://pubmed.ncbi.nlm.nih.gov/30050780
Autor:
Yi, Yang, Bai-Jun, Cheng, Hong, Jian, Zhi-Wei, Chen, Yi, Zhao, Yong-Feng, Yu, Zi-Ming, Li, Mei-Lin, Liao, Shun, Lu
Publikováno v:
American journal of translational research. 9(2)
Rapid growth of tumor cells needs to consume large amounts of oxygen and glucose, due to lack of blood supply within the tumor, cells live in an environment that lack of oxygen and nutrients. This environment results in endoplasmic reticulum (ER) str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c39fb02b0d9722bafcc248bb9605c0f
https://pubmed.ncbi.nlm.nih.gov/28337298
https://pubmed.ncbi.nlm.nih.gov/28337298
Autor:
Zhu-Ping Xiao, Hai-Liang Zhu, Mei-Lin Liao, Qun Luo, Yang Deng, Tao-Wu Ma, Zhi-Ping Li, Xiao-Chun Peng, Yu-Ting Feng, Jialiang Li, Xiao Liang, Ying Wu
Publikováno v:
European Journal of Medicinal Chemistry. 46:4904-4914
Thirty-five 3-aryl-4-arylaminofuran-2(5H)-one derivatives were designed, prepared and tested for their inhibitory activity against tyrosyl-tRNA synthetase. Out of these compounds, 3-(3-bromophenyl)-4-(3,5-dichlorophenylamino)furan-2(5H)-one (35) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89748b65e08087f12b9d5b2ec6a7a7ce
https://doi.org/10.1016/j.ejmech.2011.07.047
https://doi.org/10.1016/j.ejmech.2011.07.047
Publikováno v:
Journal of Chemical Crystallography. 41:1214-1217
The title compound, C17H14ClF2NO2, crystallizes in monoclinic space group P21/c with unit cell dimension of a = 16.276(3) A, b = 7.5030(15) A, c = 13.812(3) A, α = 90°, β = 111.11(3)°, γ = 90° and Z = 4. The structure of the title compound reve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c0e0a2ac04e9249ce5dd0579190a88e
https://doi.org/10.1007/s10870-011-0075-x
https://doi.org/10.1007/s10870-011-0075-x
Autor:
Mei Lin Liao, Martin Reck, Helge Bischoff, Mark V. Sellers, Georgina Speake, Frances A. Shepherd, Tony Mok, Vera Hirsh, Mark A. Socinski, Jean Yves Douillard, Alison Armour, Claire Watkins, Edward S. Kim, Radj Gervais
Publikováno v:
Journal of Clinical Oncology. 28:744-752
Purpose In the phase III INTEREST trial, 1,466 pretreated patients with advanced non–small cell lung cancer (NSCLC) were randomly assigned to receive gefitinib or docetaxel. As a preplanned analysis, we prospectively analyzed available tumor biopsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67fcf3b30bcac631ea1cdc9157086ce3
https://doi.org/10.1200/jco.2009.24.3030
https://doi.org/10.1200/jco.2009.24.3030
Autor:
Jean-Yves Douillard, Yan Sun, Claire Watkins, Edward S. Kim, Mark V. Sellers, Alison Armour, Mei Lin Liao, Mark A. Socinski, Frances A. Shepherd, Yi-Long Wu, Long Yun Li, Radj Gervais, Scott M. Lippman, Martin Reck, Kell Østerlind, Tony Mok, Vera Hirsh, Elizabeth S. Lowe
Publikováno v:
The Lancet. 372:1809-1818
Summary Background Two phase II trials in patients with previously-treated advanced non-small-cell lung cancer suggested that gefitinib was efficacious and less toxic than was chemotherapy. We compared gefitinib with docetaxel in patients with locall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::999a5327ce78481a1eb1a247df44732f
https://doi.org/10.1016/s0140-6736(08)61758-4
https://doi.org/10.1016/s0140-6736(08)61758-4
Publikováno v:
Chinese Journal of Cancer Research. 14:216-219
Objective: To investigate the relationship between co-deletion of p15/p16 genes and the prognostic significance in patients with non-small cell lung cancer (NSCLC). Methods: By using polymerase chain reaction (PCR), the loss of p15/p16 genes was exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb05f7bced26edda0480cecd3ca957d6
https://doi.org/10.1007/s11670-002-0048-x
https://doi.org/10.1007/s11670-002-0048-x
Publikováno v:
Chinese Journal of Cancer Research. 12:220-223
Objective: To explore the change of pathology and the clinical response rate treated by neoadjuvant chemotherapy with MVP regimen for non-small cell lung cancer. Methods: This is a randomized study in patients with stage I-IIIa. Among them, 46 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aea761863f9b9a9af19f11a035ab9407
https://doi.org/10.1007/bf02983472
https://doi.org/10.1007/bf02983472
Autor:
Yan, Sun, Yi-long, Wu, Long-yun, Li, Mei-lin, Liao, Guo-liang, Jiang, Edward S, Kim, Jean-yves, Douillard, Tsveta, Milenkova
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 33(5)
To compare the efficacy and safety of gefitinib or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed previous platinum-based first-line chemotherapy.We retrospectively reviewed 222 Chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43b3c9773b050ee8dd179acb99d8703a
https://pubmed.ncbi.nlm.nih.gov/21875470
https://pubmed.ncbi.nlm.nih.gov/21875470